EXPERIMENTAL DRUG TRIAL FOR BUNDIBUGYO EBOLA VIRUS
EXPERIMENTAL DRUG TRIAL FOR BUNDIBUGYO EBOLA VIRUS Why in the News? Clinical Trial: The Democratic Republic of Congo (DRC) has launched a clinical trial to evaluate Gilead Sciences’ experimental antiviral […]